Led · Seed · Dec 2018

Avive Solutions develops the Avive Connect AED, a connected automated external defibrillator, alongside complementary software. The Avive Connect AED emphasizes portability, accessibility and connectivity and is paired with the REALConnect platform to streamline AED ownership and management. Avive also provides an intelligent response platform designed to deliver comprehensive cardiac arrest response capabilities to communities. The company is led by CEO Sameer Jafri and is based in San Francisco. In April 2024 Avive closed a $56.5M Growth Equity financing to support its commercial expansion. The company plans to use the proceeds to accelerate U.S. commercial developments and to expand its team with additional talent. Avive Solutions is a healthcare technology company building a connected automated external defibrillator (AED) paired with a software platform that integrates with public safety and provider ecosystems to address out-of-hospital cardiac arrest (OHCA). The platform connects with 911 Emergency Communications Centers via a partnership with RapidSOS and provides incident data-sharing to close data gaps during cardiac arrest responses. Avive has developed the "4-Minute City" program, which places AEDs strategically across municipalities combined with community training to promote early intervention and equitable outcomes. The company aims to increase survival rates from cardiac arrest and reduce disparities tied to socioeconomic and demographic factors. Led by co-founder and CEO Sameer Jafri and based in San Francisco, Avive closed a $22M Series A to advance its technology-enabled approach to improving OHCA survival rates. Avive Solutions is a San Francisco–based healthcare technology company developing a next-generation AED paired with a first-of-its-kind platform to revolutionize out-of-hospital cardiac arrest response. The company aims to increase SCA survival rates by combining advanced, affordable hardware with data-driven software and integrations into the emergency response ecosystem. Avive emphasizes accessible CPR training features, rapid defibrillation workflows, and a data link to professional first responders. Funding will be used to prepare for commercial launch pending FDA approval and to accelerate platform development and ecosystem integrations. Founded in 2017, Avive has raised over $15 million to date and is in the midst of the FDA review cycle. The company situates its product strategy around shortening time-to-defibrillation to address U.S. out-of-hospital SCA, which accounts for over 350,000 deaths annually and has national average survival rates below 10%. Revive Solutions is a San Francisco-based healthcare technology company developing a next-generation automated external defibrillator and accompanying software aimed at increasing survival from sudden cardiac arrest. The product is described as ultra-portable, easy to maintain, affordable, and simple for bystanders to use effectively. Revive positions its device to address limited AED accessibility caused by bulk, intimidating interfaces, maintenance burdens, and high price points. Proceeds from the recent financing will be used to complete the regulatory submission and pursue commercial launch upon FDA approval. The company emphasizes bringing a modernized, accessible AED to market to improve stagnant survival rates. To date, Revive has raised over $6M.

Participated · Series A · Dec 2017

Caption Health develops Caption AI, an AI-guided medical imaging acquisition system that helps healthcare providers perform ultrasound and obtain diagnostic-quality images. The platform includes Caption Guidance, which provides 90-plus types of real-time feedback to emulate an expert sonographer and perform automated quality assessment, and Caption Interpretation, which produces automated ejection fraction calculations from common cardiac ultrasound views. Caption AI is available fully integrated with a Terason uSmart 3200T Plus portable ultrasound system and supports a range of clinical applications including lung, vascular, and abdominal scanning. Led by CEO Charles Cadieu, the company intends to scale commercial operations, continue developing its AI technology platform, and form new partnerships to expand use of Caption AI in additional care settings. The company closed a $53M Series B funding round to support those efforts. Bay Labs is a San Francisco–based medical technology company founded in 2013 that applies deep learning to cardiovascular imaging. Its core product uses AI algorithms to help medical professionals of all skill levels perform and interpret echocardiograms. The company has partnered with Minneapolis Heart Institute and Allina Health, Northwestern Medicine, Duke University School of Medicine, and Stanford cardiologists to develop, test and validate its algorithms. Bay Labs says its products are for investigational use only and are not currently for sale. The company plans to continue clinical validation, accelerate technological development, and bring its products to the U.S. market. Recently it completed a financing to support those efforts.